Bluebird opens manufacturing facility as it moves gene therapies forward

Bluebird opens manufacturing facility as it moves gene therapies forward

Source: 
Fierce Pharma
snippet: 

In an indication of where the growth in the pharma industry is developing, Bluebird Bio is the latest to complete a viral vector manufacturing facility to produce gene and cell therapies.